Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPALA ERAS
NCT07224711Phase 4Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Vanderbilt University Medical Center. Started Oct 2026; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07224711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224711.